Drug Delivery Systems for Anti-infectious, Anti-inflammatory and Anti-cancer Agents

Dear Colleagues,

Despite the continuous development of new therapeutic methods allowing for more and more effective treatment of infectious, inflammatory, and neoplastic diseases, a number of clinically relevant issues, including the low specificity of some therapeutics as well as their high toxicity, have still not been resolved. The constantly growing phenomenon of drug resistance is also an extremely important problem. Notably, a reduction in therapeutic activity has been observed both in antimicrobial and anticancer drugs, which significantly increases the costs of hospitalization for patients, demands the use of potentially more toxic drug combinations, and increases the mortality among patients suffering from these life-threating medical conditions.

The available literature data indicate that the answer to these issues may be the use of drug delivery systems (DDS), which not only increase the therapeutic effectiveness of the drugs incorporated in such formulations, but also modulate their biological activity. The broad spectrum of available drug carriers, both of organic and inorganic origin, makes their employment a promising approach for the safe and effective therapy of drug-resistant infections, chronic inflammation, or malignancies. This Special Issue aims to expand our knowledge of newly developed drug delivery vehicles as well as explore novel possibilities to improve pharmacokinetic and pharmodynamic features of available drugs using those systems.

Dr. Ewelina Piktel
Dr. Urszula Wnorowska
Prof. Dr. Bogumil E. Brycki
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.